Shandong Buchang Pharmaceuticals Co (SHSE:603858) Loans Receivable: ¥0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603858 Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858
70 GF Score
Price ¥14.62
GF Value ¥15.33
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shandong Buchang Pharmaceuticals Co Loans Receivable?

Shandong Buchang Pharmaceuticals Co SHSE:603858 +1.11% 70 Loans Receivable is ¥0 Mil as of Jun. 2026. GuruFocus rates SHSE:603858 with a GF Score™ of 70/100 and a GF Value™ of ¥15.33 (Fairly Valued). The stock has 6 warning signs investors should review.

Shandong Buchang Pharmaceuticals Co's Loans Receivable for the quarter that ended in Jun. 2026 was ¥0 Mil.

Shandong Buchang Pharmaceuticals Co Loans Receivable Related Terms

Shandong Buchang Pharmaceuticals Co Loans Receivable Historical Data

* Premium members only.

The historical data trend for Shandong Buchang Pharmaceuticals Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Buchang Pharmaceuticals Co Loans Receivable Chart

Shandong Buchang Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shandong Buchang Pharmaceuticals Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:603858
70GF Score
Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Buchang Pharmaceuticals Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of ¥0 Mil mean?
Shandong Buchang Pharmaceuticals Co (SHSE:603858) has a Loans Receivable of ¥0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors.
Is Shandong Buchang Pharmaceuticals Co's Loans Receivable too high?
Shandong Buchang Pharmaceuticals Co's current Loans Receivable is ¥0 Mil. Overall, Shandong Buchang Pharmaceuticals Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Buchang Pharmaceuticals Co's Loans Receivable compare to ZTS?
Shandong Buchang Pharmaceuticals Co's Loans Receivable of ¥0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Drug Manufacturers company?
A good Loans Receivable depends on the Drug Manufacturers industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors. Shandong Buchang Pharmaceuticals Co's current Loans Receivable is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Buchang Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co (SHSE:603858) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.33, compared to a current price of ¥14.62 — trading 4.6% below its estimated fair value. The current Loans Receivable is ¥0 Mil. Shandong Buchang Pharmaceuticals Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Shandong Buchang Pharmaceuticals Co (SHSE:603858), the current Loans Receivable is ¥0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Buchang Pharmaceuticals Co (SHSE:603858) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥14.62 is trading 4.6% below its estimated GF Value™ of ¥15.33. GuruFocus considers Shandong Buchang Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:603858:

  • Loans Receivable: ¥0 Mil
  • GF Value™: ¥15.33 vs. price of ¥14.62 (4.6% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603858 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Buchang Pharmaceuticals Co Business Description

Address No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000
Shandong Buchang Pharmaceuticals Co Ltd is engaged in research and development, production and sales of Chinese patent medicines.
70GF Score

Get the complete analysis for SHSE:603858

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.62
Price
¥15.33
GF Value